Lung cancer
Conditions
Interventions
Control group:No
Experimental group1:0.2% ropivacaine
Experimental group2:0.3% ropivacaine
Experimental group3:0.4% ropivacaine
Sponsors
Affiliated Hospital of Jiaxing College
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Unilateral thoracoscopic lobutomy was performed in the First Hospital of Jiaxing City from May 2021 to August 2021, including 120 patients; 2.Aged 18~80 years,; 3.ASA I~III Grade.
Exclusion criteria
Exclusion criteria: 1. Patients in shock or coma; 2. Patients with abnormal heart, lung, liver, kidney and coagulation function; 3. In patients with infection in the block area, severe nerve injury occurred in the limb of the block side; 4. Patients with chronic pain, history of taking analgesics, psychosis, radiotherapy and chemotherapy, and contraindications to non steroidal anti-inflammatory drugs; 5. Patients allergic to local anesthetics such as lidocaine, ropivacaine and general anesthetics; 6. Patients and their family members refused anesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical scale pain score;Opioid use;quality of recovery scores (QoR-40); | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting;Time of first pain; | — |
Countries
China
Contacts
Public ContactJiang Chenwei
Jiaxing First Hospital
Outcome results
None listed